This kind of behavior is documented for humans, e.g., by NmU overexpression [60], a protein involved in breast cancer progression and metastization [61], or by an increased activity of the enzyme cytochrome P4503A4 [62], leading to resistance to therapy. Here, NMU is linked to breast carcinoma.